SEC Form 4 · accession 0001179110-17-010640
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jul 19, 2017
Accepted (ET)
Jul 24, 2017 · 9:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 19, 2017 | S | 20,786 | $10.50 | D | 2,421,367 | D | |
| Ordinary Shares | Jul 20, 2017 | S | 23,445 | $10.50 | D | 2,397,922 | D |
Table II — derivative securities
No Table II lines on this filing.